Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
Stockholm · SEK · Healthcare · Drug Manufacturers - Specialty & Generic
SEK 1.67 (+4.06%) as of
Key statistics
- Market cap
- 50.61M
- EPS (TTM)
- -0.8900
- Dividend yield
- 0.00%
- 52-week range
- 0.7600 – 7.8800
- Beta
- 1.26
- Revenue (TTM)
- 35.02M
- Profit margin
- -76.85%
- Volume
- 121.90k
About Newbury Pharmaceuticals AB (publ)
Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Lund, Sweden
- Employees
- 7
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.